Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum

Neuroscience Letters

Volumn 212, Issue 1, 1996, Pages 53-56

  Okada, Motohiro ^a   Mizuno, Kazuhisa ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

A1 receptor; A2a receptor; A2b receptor; Adenosine; Caffeine; Dopamine release; Microdialysis; Striatum

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; CAFFEINE; DOPAMINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; GENE EXPRESSION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030570390     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12780-4     Document Type: Article

References (20)

1. [1] Apfeldorf, W.J. and Shear, M.K., Caffeine potentiation of taste in panic-disorder patients, Biol. Psychiatry, 33 (1993) 217-219.
2. [2] Barraco, R.A. and Stefano, G.B., Pharmacological evidence for the modulation of monoamine release by adenosine in the invertebrate nervous system, J. Neurochem., 54 (1990) 2002-2006.
3. [3] Barraco, R.A., Clough-Helfman, C., Goodwin, B.P. and Anderson, G.F., Evidence for presynaptic adenosine A2a receptors associated with norepinephrine release and their desensitization in the rat nucleus tractus solitarius, J. Neurochem., 65 (1995) 1604-1611.
4. [4] Daval, J.L., Decken, J., Weiss, S.R.B., Post, R.M. and Marangos, P.J., Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitive autoradiographic study, Epilepsia, 30 (1989) 26-33.
5. [5] Gilliland, K. and Andress, D., Ad lib caffeine consumption, symptoms of caffeinism, and academic performance, Am. J. Psychiatry, 138 (1981) 512-514.
6. 3H]acetylcholine release, J. Neurochem., 62 (1994) 960-966.
7. [7] Lee, K.S. and Reddington, M., Autoradiographic evidence for multiple CNS binding sites for adenosine derivates, Neuroscience, 9 (1986) 535-549.
8. [8] Lupica, C.R., Cass, W.A., Zahniser, N.R. and Dunwiddie, T.V., Effects of the selective adenosine A2 receptor agonist CGS21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum, J. Pharmacol. Exp. Ther., 252 (1990) 1134-1141.
9. 2+ current in hippocampal CA3 neurons, Neuron, 10 (1993) 327-334.
10. 2+ dependent dopamine release, Epilepsy Res., 13 (1992) 113-119.
11. [11] Okada, M., Kaneko, S., Hirano, T., Mizuno, K., Kondo, T., Otani, K. and Fukushima, Y., Effects of zonisamide on dopaminergic system, Epilepsy Res., 22 (1995) 193-205.
12. [12] Okada, M., Mizuno, K., Okuyama, M. and Kaneko, S., Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum, Psychiatry Clin. Neurosci., 50 (1996) 147-156.
13. [13] Pitchot, W., Ansseau, M., Moreno, A.G., Hansenne, M. and von Frenckell, R., Dopaminergic function in panic disorder: comparison with major and minor depression, Biol. Psychiatry, 32 (1992) 1004-1011.
14. [14] Reddington, M. and Lee, K.S., Adenosine receptor subtypes: classification and distribution. In T.W. Stone (Ed.), Adenosine in the Nervous System, Academic Press, London, 1991, pp. 77-102.
15. [15] Stone, T.W. and Bartrup, J.T., Electropharmacology of adenosine. In T.W. Stone (Ed.), Adenosine in the Nervous System, Academic Press, London, 1991, pp. 197-216.
16. [16] Takahashi, T. and Momiyama, A., Different types of calcium channels mediate central synaptic transmission, Nature, 366 (1993) 156-158.
17. 2+ channels in supporting hippocampal synaptic transmission, Science, 264 (1994) 107-111.
18. [18] Wojcik, W.J. and Neff, N.H., Differential location of adenosine A1 and A2 receptors in striatum, Neurosci. Lett., 41 (1983) 55-60.
19. [19] Wood, P.L., Kim, H.S., Boyar, W.C. and Hutchison, A., Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonist: A1 receptor mediation, Neuropharmacology, 28 (1989) 21-25.
20. [20] Zetterstrom, T. and Fillenz, M., Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release, Eur. J. Pharmacol., 180 (1990) 137-143.